PALLESCHI, MICHELA
PALLESCHI, MICHELA
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors
2025 Scafetta, Roberta; Donato, Marco; Gullotta, Carla; Guarino, Alessandra; Fiore, Cristina; Sisca, Luisana; Speziale, Elena; Troiano, Raffaella; Foderaro, Simone; Ricozzi, Valentina; Iuliani, Michele; Simonetti, Sonia; Cavaliere, Silvia; Cortellini, Alessio; Botticelli, Andrea; Scagnoli, Simone; Pisegna, Simona; Criscitiello, Carmen; Pedersini, Rebecca; Sposetti, Caterina; Tiberi, Elisa; D'Auria, Giuliana; Vergati, Matteo; Mazzotta, Marco; Caputo, Roberta; Verrazzo, Annarita; Grazia Rossino, Maria; Domati, Federica; Piombino, Claudia; Sofia Di Lisa, Francesca; Filomeno, Lorena; Arcuri, Teresa; Puce, Federica; Riva, Federica; Palleschi, Michela; Sirico, Marianna; Piras, Marta; Stefania Stucci, Luigia; De Lisi, Delia; Orsaria, Paolo; Ippolito, Edy; Ramella, Sara; Visani, Luca; Bertini, Niccolò; Bonaparte, Ilaria; Gori, Stefania; Rossi, Luigi; Meattini, Icro; Tagliaferri, Barbara; Caffo, Orazio; Portarena, Ilaria; Irelli, Azzurra; Cretella, Elisabetta; Porta, Camillo; Bianchini, Giampaolo; Fabbri, Agnese; De Giorgi, Ugo Federico Francesco; Vici, Patrizia; Toss, Angela; Garrone, Ornella; De Laurentiis, Michelino; Villa, Federica; Berardi, Rossana; Minelli, Mauro; Vernieri, Claudio; Curigliano, Giuseppe; Vincenzi, Bruno; Tonini, Giuseppe; Santini, Daniele; Pantano, Francesco
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants
2025 Palleschi, M.; Virga, A.; Scarpi, E.; Fonzi, E.; Musolino, A.; Merloni, F.; Sarti, S.; Danesi, R.; Ravegnani, M.; Casadei, C.; Sirico, M.; Gianni, C.; Maltoni, R.; Bravaccini, S.; Calistri, D.; Arcangeli, V.; Zampiga, V.; Cangini, I.; Bandini, E.; Mannozzi, F.; Falcini, F.; Martinelli, G.; De Giorgi, U.; Ulivi, P.; Tedaldi, G.
Transcriptomic profiling of circulating tumor cells from metastatic breast cancer patients reveals new hints in their biological features and phenotypic heterogeneity
2025 Rossi, Tania; Bandini, Sara; Zanoni, Michele; Cortesi, Michela; Palleschi, Michela; Bandini, Erika; Rocca, Andrea; Gallerani, Giulia; Vannini, Ivan; Plousiou, Meropi; Gerratana, Lorenzo; Musolino, Antonino; Tallini, Giovanni; Martinelli, Giovanni; De Giorgi, Ugo; Ulivi, Paola
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy
2024 Roberta Maltoni; Andrea Roncadori; William Balzi; Massimiliano Mazza; Fabio Nicolini; Michela Palleschi; Paola Ulivi; Sara Bravaccini
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET
2024 Gennari, A; Brain, E; De Censi, A; Nanni, O; Wuerstlein, R; Frassoldati, A; Cortes, J; Rossi, V; Palleschi, M; L Alberini, J; Matteucci, F; Piccardo, A; Sacchetti, G; Ilhan, H; D'Avanzo, F; Ruffilli, B; Nardin, S; Monti, M; Puntoni, M; Fontana, V; Boni, L; Harbeck, N
HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer
2024 Cortesi, M.; Bravaccini, S.; Ravaioli, S.; Petracci, E.; Angeli, D.; Tumedei, M. M.; Balzi, W.; Pirini, F.; Zanoni, M.; Possanzini, P.; Rocca, A.; Palleschi, M.; Ulivi, P.; Martinelli, G.; Maltoni, R.
Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond
2024 Sirico, M.; Jacobs, F.; Molinelli, C.; Nader-Marta, Guilherme; Debien, V.; Faith Dewhurst, H.; Palleschi, M.; Merloni, F.; Gianni, C.; De Giorgi, U.; De Azambuja, Evandro
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study
2024 Roberta Caputo, Andrea Botticelli; Scagnoli, Simone; Pisegna Michelino De Laurentiis, Simona; Curigliano, Giuseppe; Lambertini, Matteo; Pantano Antonella Palazzo, Francesco; Paris, Ida; Vernieri, Claudio; Tedesco, Beatrice; Giampaglia, Marianna; Palleschi, Michela; Ballatore, Zelmira; Alesini, Daniele; D’Auria, Giuliana; Fabbri, Agnese; Rossi, Luigi; Verrazzo, Annarita; Scafetta, Roberta; Marinelli, Daniele; Sposetti Vittoria Barberi, Caterina; Strigari, Lidia; Marchetti, Paolo; Santini, Daniele; Fabi, Alessandra
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial.
2023 Munzone E, Regan MM, Cinieri S, Montagna E, Orlando L, Shi R, Campadelli E, Gianni L, Palleschi M, Petrelli F, Bengala C, Generali D, Collovà E, Puglisi F, Cretella E, Zamagni C, Chini C, Ruepp B, Loi S, Colleoni M; International Breast Cancer Study Group (IBCSG).
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
2023 Merloni F.; Palleschi M.; Gianni C.; Casadei C.; Curcio A.; Romeo A.; Rocchi M.; Cima S.; Sirico M.; Sarti S.; Cecconetto L.; Mariotti M.; Di Menna G.; De Giorgi U.
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives
2023 Sirico, Marianna; Virga, Alessandra; Conte, Benedetta; Urbini, Milena; Ulivi, Paola; Gianni, Caterina; Merloni, Filippo; Palleschi, Michela; Gasperoni, Marco; Curcio, Annalisa; Saha, Debjani; Buono, Giuseppe; Muñoz, Montserrat; De Giorgi, Ugo; Schettini, Francesco
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure
2023 Merloni, Filippo; Palleschi, Michela; Casadei, Chiara; Romeo, Antonino; Curcio, Annalisa; Casadei, Roberto; Stella, Franco; Ercolani, Giorgio; Gianni, Caterina; Sirico, Marianna; Cima, Simona; Sarti, Samanta; Cecconetto, Lorenzo; Di Menna, Giandomenico; De Giorgi, Ugo
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer
2023 Gianni C.; Palleschi M.; Merloni F.; Bleve S.; Casadei C.; Sirico M.; Di Menna G.; Sarti S.; Cecconetto L.; Mariotti M.; De Giorgi U.
Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study
2023 Pisegna, S.; Scagnoli, S.; Toss, A.; Caputo, R.; De Laurentiis, M.; Palleschi, M.; De Giorgi, U.; Cortesi, E.; Fabbri, M.A.; Fabi, A.; Paris, I.; Orlandi, A.; Curigliano, G.; Criscitiello, C.; Garrone, O.; Tomasello, G.; D{'}Auria, G.; Vici, P.; Ricevuto, E.; Domati, F.; Piombino, C.; Parola, S.; Scafetta, R.; Cirillo, A.; Salimbeni, B.T.; Di Lisa, F.S.; Strigari, L.; Preissner, R.; Simmaco, M.; Santini, D.; Marchetti, P.; Botticelli, A.
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
2023 Schepisi G.; Gianni C.; Palleschi M.; Bleve S.; Casadei C.; Lolli C.; Ridolfi L.; Martinelli G.; De Giorgi U.
Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient
2022 Vannini I.; Urbini M.; Melloni M.; Rossi T.; Gallerani G.; Palleschi M.; Azzali I.; Puccetti M.; Martinelli G.; Fabbri F.
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer
2022 Gianni, Caterina; Palleschi, Michela; Merloni, Filippo; Di Menna, Giandomenico; Sirico, Marianna; Sarti, Samanta; Virga, Alessandra; Ulivi, Paola; Cecconetto, Lorenzo; Mariotti, Marita; De Giorgi, Ugo
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment
2022 Gianni C.; Palleschi M.; Schepisi G.; Casadei C.; Bleve S.; Merloni F.; Sirico M.; Sarti S.; Cecconetto L.; Di Menna G.; Schettini F.; De Giorgi U.
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab
2022 Palleschi M.; Prochowski Iamurri A.; Scarpi E.; Mariotti M.; Maltoni R.; Mannozzi F.; Barone D.; Paganelli G.; Casi M.; Giampalma E.; De Giorgi U.; Rocca A.
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis
2022 Rossi T.; Angeli D.; Tebaldi M.; Fici P.; Rossi E.; Rocca A.; Palleschi M.; Maltoni R.; Martinelli G.; Fabbri F.; Gallerani G.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors | Scafetta, Roberta; Donato, Marco; Gullotta, Carla; Guarino, Alessandra; Fiore, Cristina; Sisca, L...uisana; Speziale, Elena; Troiano, Raffaella; Foderaro, Simone; Ricozzi, Valentina; Iuliani, Michele; Simonetti, Sonia; Cavaliere, Silvia; Cortellini, Alessio; Botticelli, Andrea; Scagnoli, Simone; Pisegna, Simona; Criscitiello, Carmen; Pedersini, Rebecca; Sposetti, Caterina; Tiberi, Elisa; D'Auria, Giuliana; Vergati, Matteo; Mazzotta, Marco; Caputo, Roberta; Verrazzo, Annarita; Grazia Rossino, Maria; Domati, Federica; Piombino, Claudia; Sofia Di Lisa, Francesca; Filomeno, Lorena; Arcuri, Teresa; Puce, Federica; Riva, Federica; Palleschi, Michela; Sirico, Marianna; Piras, Marta; Stefania Stucci, Luigia; De Lisi, Delia; Orsaria, Paolo; Ippolito, Edy; Ramella, Sara; Visani, Luca; Bertini, Niccolò; Bonaparte, Ilaria; Gori, Stefania; Rossi, Luigi; Meattini, Icro; Tagliaferri, Barbara; Caffo, Orazio; Portarena, Ilaria; Irelli, Azzurra; Cretella, Elisabetta; Porta, Camillo; Bianchini, Giampaolo; Fabbri, Agnese; De Giorgi, Ugo Federico Francesco; Vici, Patrizia; Toss, Angela; Garrone, Ornella; De Laurentiis, Michelino; Villa, Federica; Berardi, Rossana; Minelli, Mauro; Vernieri, Claudio; Curigliano, Giuseppe; Vincenzi, Bruno; Tonini, Giuseppe; Santini, Daniele; Pantano, Francesco | 2025-01-01 | JOURNAL OF BREAST CANCER RESEARCH AND ADVANCEMENTS | - | 1.01 Articolo in rivista | THE BREAST DENOSUMAB VERSUS ZOLEDRONATO.pdf; 1-s2.0-S0960977625005193-mmc1.pdf |
| Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants | Palleschi, M.; Virga, A.; Scarpi, E.; Fonzi, E.; Musolino, A.; Merloni, F.; Sarti, S.; Danesi, R....; Ravegnani, M.; Casadei, C.; Sirico, M.; Gianni, C.; Maltoni, R.; Bravaccini, S.; Calistri, D.; Arcangeli, V.; Zampiga, V.; Cangini, I.; Bandini, E.; Mannozzi, F.; Falcini, F.; Martinelli, G.; De Giorgi, U.; Ulivi, P.; Tedaldi, G. | 2025-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | The Oncologist.pdf; file supplementari.zip |
| Transcriptomic profiling of circulating tumor cells from metastatic breast cancer patients reveals new hints in their biological features and phenotypic heterogeneity | Rossi, Tania; Bandini, Sara; Zanoni, Michele; Cortesi, Michela; Palleschi, Michela; Bandini, Erik...a; Rocca, Andrea; Gallerani, Giulia; Vannini, Ivan; Plousiou, Meropi; Gerratana, Lorenzo; Musolino, Antonino; Tallini, Giovanni; Martinelli, Giovanni; De Giorgi, Ugo; Ulivi, Paola | 2025-01-01 | EXPERIMENTAL HEMATOLOGY & ONCOLOGY | - | 1.01 Articolo in rivista | 40164_2025_Article_659.pdf |
| An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy | Roberta Maltoni; Andrea Roncadori; William Balzi; Massimiliano Mazza; Fabio Nicolini; Michela Pal...leschi; Paola Ulivi; Sara Bravaccini | 2024-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | biomedicines-12-00498-v2.pdf |
| Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET | Gennari, A; Brain, E; De Censi, A; Nanni, O; Wuerstlein, R; Frassoldati, A; Cortes, J; Rossi, V; ...Palleschi, M; L Alberini, J; Matteucci, F; Piccardo, A; Sacchetti, G; Ilhan, H; D'Avanzo, F; Ruffilli, B; Nardin, S; Monti, M; Puntoni, M; Fontana, V; Boni, L; Harbeck, N | 2024-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer | Cortesi, M.; Bravaccini, S.; Ravaioli, S.; Petracci, E.; Angeli, D.; Tumedei, M. M.; Balzi, W.; P...irini, F.; Zanoni, M.; Possanzini, P.; Rocca, A.; Palleschi, M.; Ulivi, P.; Martinelli, G.; Maltoni, R. | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-16-03752.pdf; cancers-16-03752-s001.zip |
| Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond | Sirico, M.; Jacobs, F.; Molinelli, C.; Nader-Marta, Guilherme; Debien, V.; Faith Dewhurst, H.; Pa...lleschi, M.; Merloni, F.; Gianni, C.; De Giorgi, U.; De Azambuja, Evandro | 2024-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | PI3K paper.pdf |
| Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study | Roberta Caputo, Andrea Botticelli; Scagnoli, Simone; Pisegna Michelino De Laurentiis, Simona; Cur...igliano, Giuseppe; Lambertini, Matteo; Pantano Antonella Palazzo, Francesco; Paris, Ida; Vernieri, Claudio; Tedesco, Beatrice; Giampaglia, Marianna; Palleschi, Michela; Ballatore, Zelmira; Alesini, Daniele; D’Auria, Giuliana; Fabbri, Agnese; Rossi, Luigi; Verrazzo, Annarita; Scafetta, Roberta; Marinelli, Daniele; Sposetti Vittoria Barberi, Caterina; Strigari, Lidia; Marchetti, Paolo; Santini, Daniele; Fabi, Alessandra | 2024-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
| Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial. | Munzone E, Regan MM, Cinieri S, Montagna E, Orlando L, Shi R, Campadelli E, Gianni L, Palleschi M..., Petrelli F, Bengala C, Generali D, Collovà E, Puglisi F, Cretella E, Zamagni C, Chini C, Ruepp B, Loi S, Colleoni M; International Breast Cancer Study Group (IBCSG). | 2023-01-01 | JAMA ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology | Merloni F.; Palleschi M.; Gianni C.; Casadei C.; Curcio A.; Romeo A.; Rocchi M.; Cima S.; Sirico ...M.; Sarti S.; Cecconetto L.; Mariotti M.; Di Menna G.; De Giorgi U. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Merloni_2023.pdf |
| Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives | Sirico, Marianna; Virga, Alessandra; Conte, Benedetta; Urbini, Milena; Ulivi, Paola; Gianni, Cate...rina; Merloni, Filippo; Palleschi, Michela; Gasperoni, Marco; Curcio, Annalisa; Saha, Debjani; Buono, Giuseppe; Muñoz, Montserrat; De Giorgi, Ugo; Schettini, Francesco | 2023-01-01 | CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY | - | 1.01 Articolo in rivista | Sirico_Neoadjuvant endocrine therapy for luminal breast tumors_2023_january.pdf |
| Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure | Merloni, Filippo; Palleschi, Michela; Casadei, Chiara; Romeo, Antonino; Curcio, Annalisa; Casadei..., Roberto; Stella, Franco; Ercolani, Giorgio; Gianni, Caterina; Sirico, Marianna; Cima, Simona; Sarti, Samanta; Cecconetto, Lorenzo; Di Menna, Giandomenico; De Giorgi, Ugo | 2023-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | 2023-Merloni (Ther Adv Med Oncol)- Oligometastatic breast cancer REVIEW.pdf |
| Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer | Gianni C.; Palleschi M.; Merloni F.; Bleve S.; Casadei C.; Sirico M.; Di Menna G.; Sarti S.; Cecc...onetto L.; Mariotti M.; De Giorgi U. | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Potential Impact of Preoperative Circulating Biomarkers.pdf |
| Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study | Pisegna, S.; Scagnoli, S.; Toss, A.; Caputo, R.; De Laurentiis, M.; Palleschi, M.; De Giorgi, U.;... Cortesi, E.; Fabbri, M.A.; Fabi, A.; Paris, I.; Orlandi, A.; Curigliano, G.; Criscitiello, C.; Garrone, O.; Tomasello, G.; D{'}Auria, G.; Vici, P.; Ricevuto, E.; Domati, F.; Piombino, C.; Parola, S.; Scafetta, R.; Cirillo, A.; Salimbeni, B.T.; Di Lisa, F.S.; Strigari, L.; Preissner, R.; Simmaco, M.; Santini, D.; Marchetti, P.; Botticelli, A. | 2023-01-01 | ANNALS OF ONCOLOGY | - | 1.06 Abstract in rivista | - |
| The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer | Schepisi G.; Gianni C.; Palleschi M.; Bleve S.; Casadei C.; Lolli C.; Ridolfi L.; Martinelli G.; ...De Giorgi U. | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | - |
| Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient | Vannini I.; Urbini M.; Melloni M.; Rossi T.; Gallerani G.; Palleschi M.; Azzali I.; Puccetti M.; ...Martinelli G.; Fabbri F. | 2022-01-01 | FRONTIERS IN MEDICINE | - | 1.01 Articolo in rivista | Case Report Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient.pdf; Table_1.XLSX |
| Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer | Gianni, Caterina; Palleschi, Michela; Merloni, Filippo; Di Menna, Giandomenico; Sirico, Marianna;... Sarti, Samanta; Virga, Alessandra; Ulivi, Paola; Cecconetto, Lorenzo; Mariotti, Marita; De Giorgi, Ugo | 2022-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | graphic.pdf; ijms-23-14197.pdf |
| Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment | Gianni C.; Palleschi M.; Schepisi G.; Casadei C.; Bleve S.; Merloni F.; Sirico M.; Sarti S.; Cecc...onetto L.; Di Menna G.; Schettini F.; De Giorgi U. | 2022-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Circulating inflammatory cells in patients with metastatic breast cancer Implications for treatment.pdf |
| Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab | Palleschi M.; Prochowski Iamurri A.; Scarpi E.; Mariotti M.; Maltoni R.; Mannozzi F.; Barone D.; ...Paganelli G.; Casi M.; Giampalma E.; De Giorgi U.; Rocca A. | 2022-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | - |
| Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis | Rossi T.; Angeli D.; Tebaldi M.; Fici P.; Rossi E.; Rocca A.; Palleschi M.; Maltoni R.; Martinell...i G.; Fabbri F.; Gallerani G. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-03925-v2.pdf; cancers-14-03925-s001.zip |